We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA has published a draft guidance to provide drugmakers with recommendations
on how to convert OTC drug monograph labeling to OTC "Drug Facts"
format.
The FDA has issued a warning letter to the Respi Care Group
of Puerto Rico alerting the company it has committed "serious violations"
of the Federal Food, Drug, and Cosmetic Act.
A coalition of 10 large pharmaceutical firms has launched a discount card program
that could help millions of uninsured Americans save about 25 to 40 percent
on commonly used prescription drugs.
Andrx Pharmaceuticals has filed a citizen's petition with the FDA requesting
that the agency seek the advice of the FTC and the Justice Department on the
contentious issue of authorized generics.
Addex Pharmaceuticals has entered an exclusive worldwide
research collaboration and license agreement with Ortho-McNeil Pharmaceutical,
a Johnson & Johnson company, to discover, develop and commercialize novel
compounds modulating allosterically G-Protein Coupled Receptors for the treatment
of anxiety, depression, schizophrenia and Alzheimer's disease.
Specialty chemical distributor Aceto is making its first major foray into drug
production, through a deal with Three Rivers Pharmaceuticals to bring three
generic products to market.
Cambrex has announced that its subsidiary Cambrex Bio Science Wokingham has
signed an agreement for the purchase of conditionally immortalized cell lines,
related intellectual property and equipment of Xcellsyz, Newcastle Upon Tyne,
UK. Cambrex Bio Science Walkersville, also a subsidiary of Cambrex, has entered
into license agreements for Geron's proprietary telomerase technology and complementary
conditional immortalization technology from the Ludwig Institute for Cancer
Research (LICR).
ChemDiv (Chemical Diversity), a leading provider of discovery chemistry services,
with headquarters located in San Diego, Calif., has entered into a collaborative
agreement with the University of Maryland Greenebaum Cancer Center (UMGCC) in
Baltimore, Md.